National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 8,620 cases where Age is Unknown and Vaccine targets COVID-19 (COVID19) and Symptom is Acute endocarditis or Atypical mycobacterium pericarditis or Autoimmune myocarditis or Bacterial pericarditis or Carditis or Endocarditis or Endocarditis bacterial or Endocarditis enterococcal or Endocarditis noninfective or Endocarditis staphylococcal or Endocarditis viral or Eosinophilic myocarditis or Fungal endocarditis or Giant cell myocarditis or Immune-mediated myocarditis or Lupus endocarditis or Lyme carditis or Meningococcal carditis or Myocarditis or Myocarditis bacterial or Myocarditis infectious or Myocarditis septic or Myopericarditis or Pericarditis or Pericarditis constrictive or Pericarditis infective or Pericarditis lupus or Pericarditis meningococcal or Pericarditis rheumatic or Pericarditis tuberculous or Pleuropericarditis or Purulent pericarditis or Streptococcal endocarditis or Subacute endocarditis or Viral myocarditis or Viral pericarditis

Government Disclaimer on use of this data



Case Details

This is page 23 out of 862

Result pages: prev   14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32   next


VAERS ID: 1947176 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-12-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Gait inability, Paralysis, Pericarditis
SMQs:, Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Dystonia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202101733778

Write-up: developed pericarditis; became paralyzed from the knees down; unable to walk days after the Pfizer vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient''s relevant medical history and concomitant medications were not reported. The following information was reported: PERICARDITIS (hospitalization, medically significant), outcome "not recovered", described as "developed pericarditis"; PARALYSIS (hospitalization, medically significant), outcome "not recovered", described as "became paralyzed from the knees down"; GAIT INABILITY (hospitalization, medically significant), outcome "not recovered", described as "unable to walk days after the Pfizer vaccine".Therapeutic measures were taken as a result of pericarditis, paralysis, gait inability. It was reported that at the time of reporting the patient remains in a hospital, undergoing therapy to learn how to walk and function normally again. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1950763 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-12-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Asthenia, Dandruff, Joint swelling, Musculoskeletal discomfort, Myocarditis, Palpitations, Skin disorder
SMQs:, Rhabdomyolysis/myopathy (broad), Arrhythmia related investigations, signs and symptoms (broad), Guillain-Barre syndrome (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Arthritis (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Alcohol abuse (history drug/alcohol abuse); Drug abuse (history drug/alcohol abuse); Human papilloma virus test positive (previous report, unconfirmed but mentioned HPV)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202101725159

Write-up: Has some sort of skin condition on scalp that may need to be treated - visually causes dandruff".; myocarditis; swollen ankles; Potential heart Palpitations; body falling apart; back issues; Has some sort of skin condition on scalp that may need to be treated - visually causes dandruff; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A female patient in her 30''s received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 1, single and administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "history drug/alcohol abuse" (unspecified if ongoing), notes: history drug/alcohol abuse; "history drug/alcohol abuse" (unspecified if ongoing), notes: history drug/alcohol abuse; "HPV" (unspecified if ongoing), notes: previous report, unconfirmed but mentioned HPV. The patient''s concomitant medications were not reported. The following information was reported: MYOCARDITIS (medically significant) with onset 2021, outcome "unknown", described as "myocarditis"; JOINT SWELLING (non-serious) with onset 2021, outcome "unknown", described as "swollen ankles"; PALPITATIONS (non-serious) with onset 2021, outcome "unknown", described as "Potential heart Palpitations"; ASTHENIA (non-serious) with onset 2021, outcome "unknown", described as "body falling apart"; MUSCULOSKELETAL DISCOMFORT (non-serious) with onset 2021, outcome "unknown", described as "back issues"; DANDRUFF (non-serious) with onset 2021, outcome "unknown", described as "Has some sort of skin condition on scalp that may need to be treated - visually causes dandruff"; SKIN DISORDER (non-serious), outcome "unknown", described as "Has some sort of skin condition on scalp that may need to be treated - visually causes dandruff".". The lot number for bnt162b2 was not provided and will be requested during follow up.


VAERS ID: 1954267 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-12-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Atrial fibrillation, Pericarditis
SMQs:, Systemic lupus erythematosus (broad), Supraventricular tachyarrhythmias (narrow), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LENVIMA
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202101707377

Write-up: pericarditis; A fibrillation; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): EC-2016-020714 (RA). A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation; lenvatinib mesilate (LENVIMA) (Batch/Lot number: unknown) at 20 mg. The patient''s relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1), for covid-19 immunisation. The following information was reported: PERICARDITIS (medically significant), outcome "unknown", described as "pericarditis"; ATRIAL FIBRILLATION (medically significant), outcome "unknown", described as "A fibrillation". The action taken for lenvatinib mesilate was unknown. Clinical course: Patient mentioned that his thyroglobulin increased after missing 2 doses of Lenvima. He also said that in 2018 he was on Lenvima and had to decrease the dose due to bad side effects. Pfizer is a marketing authorization holder of bnt162b2 in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of bnt162b2 has submitted the same report to the regulatory authorities. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


VAERS ID: 1961100 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Illinois  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Myocarditis
SMQs:, Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20211233715

Write-up: MYOCARDITIS; This spontaneous report received from a company representative via social media (twitter) concerned a patient of unspecified age, race, ethnicity and sex. The patient''s height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin, and batch number were not reported) 1 total dose, start therapy date were not reported for prophylactic vaccination (Dose number in series 1). The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced myocarditis. The action taken with covid-19 vaccine was not applicable. The outcome of myocarditis was not reported. This report was serious (Other Medically Important Condition).; Sender''s Comments: V0: 20211233715-COVID-19 VACCINE -myocarditis. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).


VAERS ID: 1962930 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-12-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Myocarditis
SMQs:, Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202101731220

Write-up: Myocarditis; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). A 15 year-old patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient''s relevant medical history and concomitant medications were not reported. Reporter did not want the vaccine, states it is his body and his choice. His friend''s 15 year old kid (patient) died from the COVID vaccine from myocarditis. States that Pfizer needs to stop pressuring people to take the vaccine since people don''t want the vaccine. It is not safe for kids. He declined to go through a report or provide contact details, stating then the government would come after him. States to stop hiding the data. He continued to talk over call handler and informed him the call would be disconnected since he declined to go through report. It was unknown if autopsy was done. Outcome of the event was fatal on an unspecified date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: myocarditis


VAERS ID: 1967270 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Florida  
Vaccinated:2021-12-03
Onset:2021-12-13
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-12-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 3 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Blood pressure decreased, Catheterisation cardiac, Chest pain, Heart rate decreased, Laboratory test, Magnetic resonance imaging heart, Myocarditis, Troponin increased
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Metoprolol Loop Monitor implant
Current Illness:
Preexisting Conditions: Afib/ A flutter/ Supra Ventricular Tachycardia
Allergies: Penicillin Aspirin
Diagnostic Lab Data: 12/13/2021, Troponin, 16
CDC Split Type:

Write-up: After the booster shot i started a serie of chest pain problems. Ended up in the hospital admitted and was told that it was Myocarditis from the booster. after having a catheterization done, heart MRI and labs. Blood pressure dropped dramatically and heart rate.


VAERS ID: 1966603 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-12-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Myocarditis, Physical disability, Radiculitis brachial
SMQs:, Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20211230157

Write-up: MYOCARDITIS; BRACHIAL NEURITIS; LEFT ARM DISABLED; This spontaneous report received from a patient on 13-DEC-2021 and concerned a patient of unspecified age, sex, race and ethnicity. The patient''s height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (Janssen series-1) (suspension for injection, route of admin, and batch number were not reported) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced myocarditis, brachial neuritis, and left arm disabled. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the myocarditis, brachial neuritis and left arm disabled was not reported. This report was serious (Other Medically Important Condition).; Sender''s Comments: V0:This spontaneous report received from a patient of unspecified age, sex, and ethnicity who experienced myocarditis, brachial neuritis, and disabled left arm unspecified time after vaccination. No past medical history ,concurrent conditions or concomitant medications were reported. No other information is available. The outcome of the events is not reported. Information is limited in this case, and the occurrence of the events could represent background incidence of such events in the general population. However, a relationship with Janssen Covid-19 vaccine cannot be ruled out and thus the relationship is considered indeterminate.


VAERS ID: 1966710 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Vermont  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-12-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Myocarditis
SMQs:, Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20214

Write-up: Myocarditis; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDITIS (Myocarditis) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYOCARDITIS (Myocarditis) (seriousness criteria hospitalization and medically significant). The patient was treated with Surgery (Heart surgery) for Myocarditis. At the time of the report, MYOCARDITIS (Myocarditis) outcome was unknown. Concomitant Medication use information was not provided by reporter. 7 months ago patient received the 2 doses of Moderna vaccine at proper timing. It was reported that three days after the second dose he was hospitalized and diagnosed with myocarditis. He had heart surgery for this. Treatment Medication use information was not provided by reporter. This Spontaneous case concerns a male patient of an unknown age with no medical history provided, who experienced the expected serious event Myocarditis. The event of Myocarditis occurred three days after the second dose of the mRNA-1273 vaccine and he was hospitalized and diagnosed with myocarditis with heart surgery. Reportedly, the patient had received two doses of properly scheduled vaccine administration mRNA-1273 of which dates are unknown. At the time of the report Myocarditis outcome was unknown. No further information was provided. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.; Sender''s Comments: This Spontaneous case concerns a male patient of an unknown age with no medical history provided, who experienced the expected serious event Myocarditis. The event of Myocarditis occurred three days after the second dose of the mRNA-1273 vaccine and he was hospitalized and diagnosed with myocarditis with heart surgery. Reportedly, the patient had received two doses of properly scheduled vaccine administration mRNA-1273 of which dates are unknown. At the time of the report Myocarditis outcome was unknown. No further information was provided. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.


VAERS ID: 1970449 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-12-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Carditis, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20211242525

Write-up: This spontaneous report received from a patient via social media via a company representative concerned a patient of unspecified age, sex, race and ethnicity. The patient''s height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, 1 total, start therapy date were not reported for prophylactic vaccination (dose number series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient stated, "I got the Johnson & Johnson vaccine. Ended up with a clot in my right leg and heart inflammation. I stop and take a deep breath walking up stairs". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the clot in right leg and heart inflammation was not reported. This report was serious (Other Medically Important Condition).; Sender''s Comments: V0: 20211242525- COVID-19 VACCINE AD26.COV2.S- clot in right leg, heart inflammation. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).


VAERS ID: 1974271 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: West Virginia  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Chest pain, Headache, Heart rate, Heart rate increased, Myocarditis
SMQs:, Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 2021; Test Name: racing heart; Result Unstructured Data: Test Result:racing heart
CDC Split Type: USPFIZER INC202101758088

Write-up: myocarditis; chest pains; racing heart; pounding; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient. A 36 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunization more than 6 months ago. The patient''s relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 1), for COVID-19 immunization. The following information was reported: MYOCARDITIS (medically significant) with onset 2021, outcome "unknown", described as "myocarditis"; CHEST PAIN (non-serious) with onset 2021, outcome "recovered", described as "chest pains"; HEADACHE (non-serious) with onset 2021, outcome "recovered", described as "pounding"; HEART RATE INCREASED (non-serious) with onset 2021, outcome "recovered", described as "racing heart". About 14 hours after receiving the second dose, the patient developed chest pains and a pounding, racing heart. It resolved by the next day, so the patient never sought medical care. His symptoms and their presentation seem consistent with myocarditis. What was Pfizer''s recommendation for someone seeking a booster shot that had myocarditis after the second shot. The patient underwent the following laboratory tests and procedures: heart rate: (2021) racing heart. The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender''s Comments: There is not a reasonable possibility that reported myocarditis, chest pain and Heart rate increased are related to BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.


Result pages: prev   14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=23&SYMPTOMS[]=Acute_endocarditis_%2810049001%29&SYMPTOMS[]=Atypical_mycobacterium_pericarditis_%2810055036%29&SYMPTOMS[]=Autoimmune_myocarditis_%2810064539%29&SYMPTOMS[]=Bacterial_pericarditis_%2810004050%29&SYMPTOMS[]=Carditis_%2810062746%29&SYMPTOMS[]=Endocarditis_%2810014665%29&SYMPTOMS[]=Endocarditis_bacterial_%2810014666%29&SYMPTOMS[]=Endocarditis_enterococcal_%2810014671%29&SYMPTOMS[]=Endocarditis_noninfective_%2810062608%29&SYMPTOMS[]=Endocarditis_staphylococcal_%2810014684%29&SYMPTOMS[]=Endocarditis_viral_%2810061837%29&SYMPTOMS[]=Eosinophilic_myocarditis_%2810014961%29&SYMPTOMS[]=Fungal_endocarditis_%2810017529%29&SYMPTOMS[]=Giant_cell_myocarditis_%2810083635%29&SYMPTOMS[]=Immune-mediated_myocarditis_%2810082606%29&SYMPTOMS[]=Lupus_endocarditis_%2810058225%29&SYMPTOMS[]=Lyme_carditis_%2810078417%29&SYMPTOMS[]=Meningococcal_carditis_%2810027270%29&SYMPTOMS[]=Myocarditis_%2810028606%29&SYMPTOMS[]=Myocarditis_bacterial_%2810065218%29&SYMPTOMS[]=Myocarditis_infectious_%2810066857%29&SYMPTOMS[]=Myocarditis_septic_%2810028615%29&SYMPTOMS[]=Myopericarditis_%2810028650%29&SYMPTOMS[]=Pericarditis_%2810034484%29&SYMPTOMS[]=Pericarditis_constrictive_%2810034487%29&SYMPTOMS[]=Pericarditis_infective_%2810062491%29&SYMPTOMS[]=Pericarditis_lupus_%2810058149%29&SYMPTOMS[]=Pericarditis_meningococcal_%2810034492%29&SYMPTOMS[]=Pericarditis_rheumatic_%2810034496%29&SYMPTOMS[]=Pericarditis_tuberculous_%2810055069%29&SYMPTOMS[]=Pleuropericarditis_%2810059361%29&SYMPTOMS[]=Purulent_pericarditis_%2810051071%29&SYMPTOMS[]=Streptococcal_endocarditis_%2810073742%29&SYMPTOMS[]=Subacute_endocarditis_%2810042276%29&SYMPTOMS[]=Viral_myocarditis_%2810047470%29&SYMPTOMS[]=Viral_pericarditis_%2810047472%29&VAX=COVID19&VAXTYPES=COVID-19&WhichAge=range&LOWAGE=(-1)&HIGHAGE=(-1)


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166